Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily

Tomas Smutny, Sridhar Mani, Petr Pavek

Research output: Contribution to journalArticle

54 Scopus citations

Abstract

Pregnane X receptor (PXR) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcription factors and is activated by a huge variety of endobiotics and xenobiotics, including many clinical drugs. PXR plays key roles not only as a xenosensor in the regulation of both major phase I and II drug metabolism and transporters but also as a physiological sensor in the modulation of bile acid and cholesterol metabolism, glucose and lipid metabolism, and bone and endocrine homeostasis. Post-translational modifications such as phosphorylation have been shown to modulate the activity of many NRs, including PXR, and constitute an important mechanism for crosstalk between signaling pathways and regulation of genes involved in both xenobiotic and endobiotic metabolism. In addition, microRNAs have recently been shown to constitute another level of PXR activity regulation. The objective of this review is to comprehensively summarize current understanding of post-transcriptional and post-translational modifications of PXR in regulation of xenobiotic-metabolizing cytochrome P450 (CYP) genes, mainly in hepatic tissue. We also discuss the importance of PXR in crosstalk with cell signaling pathways, which at the level of transcription modify expression of genes associated with some physiological and pathological stages in the organs. Finally, we indicate that these PXR modifications may have important impacts on CYP-mediated biotransformation of some clinically used drugs.

Original languageEnglish (US)
Pages (from-to)1059-1069
Number of pages11
JournalCurrent Drug Metabolism
Volume14
Issue number10
DOIs
StatePublished - Dec 2013

    Fingerprint

Keywords

  • Cytochrome P450
  • Gene regulation
  • Induction
  • PXR
  • Post-transcriptional
  • Post-translational modification
  • Pregnane X receptor

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Cite this